Halozyme Therapeutics Inc (HALO)
39.12
+0.15
(+0.38%)
USD |
NASDAQ |
Apr 24, 16:00
39.10
-0.02
(-0.04%)
After-Hours: 20:00
Halozyme Therapeutics Gross Profit Margin (Quarterly): 77.27% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 77.27% |
| September 30, 2023 | 74.62% |
| June 30, 2023 | 77.35% |
| March 31, 2023 | 78.31% |
| December 31, 2022 | 76.79% |
| September 30, 2022 | 77.36% |
| June 30, 2022 | 77.72% |
| March 31, 2022 | 86.42% |
| December 31, 2021 | 78.84% |
| September 30, 2021 | 83.95% |
| June 30, 2021 | 83.13% |
| March 31, 2021 | 79.53% |
| December 31, 2020 | 78.41% |
| September 30, 2020 | 91.48% |
| June 30, 2020 | 89.61% |
| March 31, 2020 | 77.18% |
| December 31, 2019 | 68.91% |
| September 30, 2019 | 51.69% |
| June 30, 2019 | 95.21% |
| March 31, 2019 | 91.84% |
| December 31, 2018 | 90.67% |
| September 30, 2018 | 97.55% |
| June 30, 2018 | 97.63% |
| March 31, 2018 | 90.11% |
| December 31, 2017 | 96.05% |
| Date | Value |
|---|---|
| September 30, 2017 | 86.93% |
| June 30, 2017 | 76.92% |
| March 31, 2017 | 74.49% |
| December 31, 2016 | 79.48% |
| September 30, 2016 | 71.32% |
| June 30, 2016 | 75.08% |
| March 31, 2016 | 81.74% |
| December 31, 2015 | 83.86% |
| September 30, 2015 | 70.26% |
| June 30, 2015 | 81.23% |
| March 31, 2015 | 65.21% |
| December 31, 2014 | 79.76% |
| September 30, 2014 | 64.80% |
| June 30, 2014 | 67.78% |
| March 31, 2014 | 53.87% |
| December 31, 2013 | 71.68% |
| September 30, 2013 | 95.73% |
| June 30, 2013 | 91.12% |
| March 31, 2013 | 93.76% |
| December 31, 2012 | 97.00% |
| September 30, 2012 | 95.75% |
| June 30, 2012 | 98.16% |
| March 31, 2012 | 99.05% |
| December 31, 2011 | 97.67% |
| September 30, 2011 | 99.95% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
51.69%
Minimum
Sep 2019
95.21%
Maximum
Jun 2019
79.15%
Average
78.31%
Median
Mar 2023
Gross Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 69.55% |
| Globus Medical Inc | 56.94% |
| Denali Therapeutics Inc | -- |
| AIM ImmunoTech Inc | 81.54% |
| Protalix BioTherapeutics Inc | 15.54% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 195.6% |
| Return on Assets | 15.68% |
| Return on Invested Capital | 17.14% |
| Profit Margin (Quarterly) | 37.12% |
| Operating Margin (Quarterly) | 43.92% |
| Return on Net Operating Assets | 20.57% |